- Report
- April 2025
- 50 Pages
Global
From €2414EUR$2,650USD£2,097GBP
Pimethixene is a medication used to treat respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. It is a long-acting muscarinic antagonist (LAMA) that works by blocking the action of a certain natural substance in the body, which helps to reduce airway constriction and inflammation. Pimethixene is available in both oral and inhalation forms, and is often used in combination with other medications to treat respiratory conditions.
Pimethixene is a relatively new drug, and is not yet widely available. It is currently approved for use in the United States, Canada, and Europe, and is being studied for use in other countries. The drug is marketed by several pharmaceutical companies, including GlaxoSmithKline, Boehringer Ingelheim, and AstraZeneca. Show Less Read more